MTOR and breast carcinoma: Interestingly, we previously showed that a truncated isoform of RON, sfRON, promoted metastasis of breast cancer cells through the PI3K pathway, but that this did not depend on AKT or mTOR,18 revealing that distinct RON isoforms promote metastasis through different mechanisms.